kynuramine has been researched along with 2,3-diaminopropionic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; Li, J; Li, K; Qiu, P; Wang, S; Wu, J; Xu, L | 1 |
1 other study(ies) available for kynuramine and 2,3-diaminopropionic acid
| Article | Year |
|---|---|
β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.
Topics: Amino Acids, Diamino; Animals; beta-Alanine; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Extracellular Matrix; Kidney; Kynuramine; Male; Panax notoginseng; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2019 |